$EHTH

eHealth, Inc.

CIK:0001333493|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenue:
Total revenue	$ 33,566	$ 60,782	$ 121,584	$ 173,901
Operating costs and expenses:
Marketing and advertising	11,781	21,425	37,174	62,614
Customer care and enrollment	22,298	27,910	54,582	65,131
Technology and content	11,301	11,354	22,636	23,955
General and administrative	15,583	21,582	31,095	38,892
Impairment, restructuring and other charges	60	1,555	6,432	1,555
Total operating costs and expenses	61,023	83,826	151,919	192,147
Loss from operations	(27,457)	(23,044)	(30,335)	(18,246)
Interest expense	(4,054)	(2,348)	(8,089)	(4,996)
Other income, net	832	1,340	1,672	2,916
Loss before income taxes	(30,679)	(24,052)	(36,752)	(20,326)
Benefit from income taxes	(7,084)	(6,654)	(8,443)	(4,878)
Net loss	(23,595)	(17,398)	(28,309)	(15,448)
Preferred stock dividends	(6,201)	(5,846)	(12,334)	(11,627)
Change in preferred stock redemption value	(7,715)	(6,539)	(14,975)	(12,680)
Net loss attributable to common stockholders	$ (37,511)	$ (29,783)	$ (55,618)	$ (39,755)
Net loss per share attributable to common stockholders:
Basic (in dollars per share)	$ (1.18)	$ (0.98)	$ (1.77)	$ (1.32)
Diluted (in dollars per share)	$ (1.18)	$ (0.98)	$ (1.77)	$ (1.32)
Weighted-average number of shares used in per share amounts:
Basic (in shares)	31,780	30,404	31,458	30,202
Diluted (in shares)	31,780	30,404	31,458	30,202
Comprehensive loss:
Net loss	$ (23,595)	$ (17,398)	$ (28,309)	$ (15,448)
Unrealized gain (loss) on available for sale debt securities, net of tax	(3)	9	(30)	(28)
Foreign currency translation adjustments	176	(4)	323	2
Comprehensive loss	(23,422)	(17,393)	(28,016)	(15,474)
Commission
Revenue:
Total revenue	29,804	54,731	109,611	153,677
Other
Revenue:
Total revenue	$ 3,762	$ 6,051	$ 11,973	$ 20,224

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities:
Net loss	$ (28,309)	$ (15,448)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	980	937
Amortization of intangible assets	5,569	6,468
Stock-based compensation expense	4,588	7,665
Deferred income taxes	(8,657)	(5,195)
Asset impairment charges	303	413
Other non-cash items	913	(637)
Changes in operating assets and liabilities:
Accounts receivable	5,870	14,952
Contract assets – commissions receivable	115,508	83,486
Prepaid expenses and other assets	1,079	(514)
Accounts payable	(25,370)	(17,627)
Accrued compensation and benefits	(26,131)	(26,834)
Accrued marketing expenses	(13,403)	(12,565)
Deferred revenue	(2,537)	328
Accrued expenses and other liabilities	407	488
Net cash provided by operating activities	30,810	35,917
Investing activities:
Capitalized internal-use software and website development costs	(4,345)	(7,376)
Purchases of property and equipment and other assets	(643)	(1,893)
Purchases of marketable securities	(48,555)	(61,878)
Proceeds from redemption and maturities of marketable securities	21,109	66,500
Net cash used in investing activities	(32,434)	(4,647)
Financing activities:
Net proceeds from exercise of common stock options and employee stock purchases	102	189
Repurchase of shares to satisfy employee tax withholding obligations	(208)	(1,826)
Payments of preferred stock dividends	(3,083)	(2,906)
Net cash used in financing activities	(3,189)	(4,543)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	309	(4)
Net increase (decrease) in cash, cash equivalents and restricted cash	(4,504)	26,723
Cash, cash equivalents and restricted cash at beginning of period	76,815	42,287
Cash, cash equivalents and restricted cash at end of period	$ 72,311	$ 69,010

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 69,681	$ 73,725
Short-term marketable securities	31,367	3,495
Accounts receivable	1,818	7,688
Contract assets – commissions receivable – current	202,804	236,116
Prepaid expenses and other current assets	10,083	13,328
Total current assets	315,753	334,352
Contract assets – commissions receivable – non-current	804,806	886,614
Property and equipment, net	4,105	4,531
Operating lease right-of-use assets	6,915	8,429
Restricted cash	2,630	3,090
Other assets	23,823	25,452
Total assets	1,158,032	1,262,468
Current liabilities:
Accounts payable	2,953	28,323
Accrued compensation and benefits	14,878	41,009
Accrued marketing expenses	2,779	16,182
Lease liabilities – current	6,615	7,349
Other current liabilities	4,524	6,207
Total current liabilities	31,749	99,070
Long-term debt	114,608	112,954
Deferred income taxes – non-current	48,566	57,223
Lease liabilities – non-current	10,950	14,050
Other non-current liabilities	5,073	5,519
Total liabilities	210,946	288,816
Commitments and contingencies (Note 8)
Convertible preferred stock	406,283	382,057
Stockholders’ equity:
Common stock	46	44
Additional paid-in capital	752,110	761,495
Treasury stock, at cost	(199,998)	(199,998)
Retained earnings (deficit)	(11,586)	30,116
Accumulated other comprehensive income (loss)	231	(62)
Total stockholders’ equity	540,803	591,595
Total liabilities, convertible preferred stock and stockholders’ equity	$ 1,158,032	$ 1,262,468